Brief: Check Cap Reports Q3 Loss Per Share $0.09

Mbody Ai

18/11/2020 13:09

Nov 18 (Reuters) - Check Cap Ltd  CHEK.O :
    * CHECK-CAP REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND
CORPORATE HIGHLIGHTS
    * CHECK CAP LTD - INVESTIGATIONAL DEVICE EXEMPTION
APPLICATION
SUBMITTED TO U.S. FDA ON NOVEMBER 18, 2020 FOR PIVOTAL STUDY OF
C-SCAN
    * CHECK CAP LTD - BELIEVES THAT IT HAS SUFFICIENT CAPITAL TO
FUND
ITS ONGOING OPERATIONS AND PLANS FOR ABOUT NEXT 12 MONTHS
    * CHECK CAP LTD QTRLY NET LOSS PER ORDINARY SHARE $0.09
    * CHECK CAP - PLAN TO PROVIDE FURTHER INVESTOR UPDATE ON
TIMELINES
FOR INITIATION OF U.S. PIVOTAL STUDY, EXPECTED IN 2021,
FOLLOWING GUIDANCE FROM FDA
    * CHECK CAP -COVID-19 PANDEMIC HAS AFFECTED CO'S ABILITY TO
INITIATE PLANNED PIVOTAL STUDY, COMMENCE PILOT SALES IN ISRAEL,
EUROPE IN ORIGINAL TIMEFRAME
    * CHECK CAP LTD - CASH AND CASH EQUIVALENTS, RESTRICTED CASH
AND
SHORT-TERM BANK DEPOSITS TOTALED ABOUT $21.7 MILLION AS OF
SEPTEMBER 30, 2020

Source text for Eikon:  ID:nPn3G0YDQa 
Further company coverage:  CHEK.O 

 ((Reuters.Briefs@thomsonreuters.com;))